glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-013961
A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-013961 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | GAA peptide-pulsed autologous dendritic cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013961",
"term": "glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis.",
"abbreviation": "GAA peptide-pulsed autologous dendritic cell vaccine",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/glioma-associated-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine/"
}
Record 8,022 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.